Intravitreal bevacizumab for extrafoveal choroidal neovascularization secondary to pathologic myopia

Retina

Volumn 33, Issue 3, 2013, Pages 593-597

  Parodi, Maurizio B ^a   Iacono, Pierluigi ^b   Papayannis, Alessandro ^c   Kontadakis, Stylianos ^a   Cascavilla, Maria L ^a   Zucchiatti, Ilaria ^a   Bandello, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c Department of Obstetrics and Gynaecology   (Italy)

Author keywords

extrafoveal choroidal neovascularization; intravitreal bevacizumab injections; pathologic myopia

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIANGIOGENIC THERAPY; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEGENERATIVE MYOPIA; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84874950063     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31826b6731     Document Type: Article

References (17)

1. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: A 10-year follow-up. Ophthalmology 2003;110:1297-1305
2. Pece A, Brancato R, Avanza P, et al. Laser photocoagulation of choroidal neovascularization in pathologic myopia: Long-Term results. Int Ophthalmol 1995;18:339-344
3. Brancato R, Pece A, Avanza P, Radrizzani E. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina 1990;10:239-243
4. Secrétan M, Kuhn D, Soubrane G, Coscas G. Long-Term visual outcome of choroidal neovascularization in pathologic myopia: Natural history and laser treatment. Eur J Ophthalmol 1997;7: 307-316
5. Gelisken F, Inhoffen W, Grisanti S, Bartz-Schmidt KU. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2004;242:926-930
6. Reche-Frutos J, Calvo-González C, Donate-López J, et al. Photodynamic therapy in non-subfoveal choroidal neovascularization secondary to pathological myopia: 1-year outcome. Br J Ophthalmol 2007;91:1722-1723
7. Pece A, Vadalà M, Isola V, Matranga D. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: A long-Term follow-up study. Am J Ophthalmol 2007;143:449-454
8. Virgili G, Varano M, Giacomelli G, et al. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia. Am J Ophthalmol 2007;143:77-82
9. Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 1995;15:198-205
10. Essex RW, Tufail A, Bunce C, Aylward GW. Two-year results of surgical removal of choroidal neovascular membranes related to non-Age-related macular degeneration. Br J Ophthalmol 2007;91:649-654
11. Pierro L, Giatsidis SM, Mantovani E, Gagliardi M. Macular thickness interoperator and intraoperator reproducibility in healthy eyes using 7 optical coherence tomography instruments. Am J Ophthalmol 2010;150:199-204. e1
12. Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983;90: 923-926
13. Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 2009;147:84-93
14. Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome. Br J Ophthalmol 2009;93:448-451
15. Parodi MB, Iacono P, Papayannis A, et al. Bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia. Arch Ophthalmol 2010;128:437-442
16. Iacono P, Parodi MB, Papayannis A, et al. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Retina 2011; 31:1841-1847
17. Ikuno Y, Sayanagi K, Soga K, et al. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: One-year results. Am J Ophthalmol 2009;147: 94-100